ALK and lung carcinoma: The proportion of lung cancer in never smokers is increasing42 and is often linked to drivers in genes such as EGFR and ALK. Optimizing outcomes requires an improved understanding of resistance mechanisms to TKIs, vaccinations and immune therapies.